Recruiting
A Study of Treatment Delivery Preference In People With Kidney Cancer
NCT07872553· Phase 4· Memorial Sloan Kettering Cancer Center· Source
Contact: Sahil Doshi, MD
Recruiting
A Study of Lung Cancer Risk
NCT07701733· Memorial Sloan Kettering Cancer Center· Source
Contact: Alexis Chidi, MD, PhD
Recruiting
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
NCT07619339· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Paul Paik, MD
Recruiting
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
NCT07594522· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source
Contact: Narek Shaverdian, MD
Recruiting
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
NCT07535437· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source
Contact: Helena Yu, MD
Recruiting
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
NCT07532902· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Michael Offin, MD
Recruiting
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
NCT07089992· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Robert Maki, MD, PhD
Recruiting
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
NCT07218601· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Gaetano Rocco, MD
Recruiting
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
NCT07052916· Memorial Sloan Kettering Cancer Center· Source
Contact: Kevin Liou, MD
Recruiting
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
NCT07029217· Phase 3· Memorial Sloan Kettering Cancer Center· Source
Contact: Brandon Imber, MD
Recruiting
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Zainab Shahid, MBBS
Recruiting
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
NCT06954337· Memorial Sloan Kettering Cancer Center· Source
Contact: Erin Bange, MD, MSCE
Recruiting
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT06925724· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Maria Rubenstein, MD
Recruiting
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
NCT06717334· Memorial Sloan Kettering Cancer Center· Source
Contact: Alexis Chidi, MD, PhD
Recruiting
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
NCT06698003· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Steven Horwitz, MD
Recruiting
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
NCT06377566· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Robert Stuver, MD
Active, not recruiting
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
NCT06209567· Early phase 1· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
NCT06132945· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Recruiting
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
NCT06129903· Memorial Sloan Kettering Cancer Center· Source
Contact: Meredith Bartelstein, MD
Enrolling by invitation
A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy
NCT06113315· Memorial Sloan Kettering Cancer Center· Source
Recruiting
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
NCT06066333· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Nitya Raj, MD
Recruiting
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06055894· Memorial Sloan Kettering Cancer Center· Source
Contact: Urvi A Shah, MD, MS
Recruiting
Using Urine Samples to Identify Lung Cancer
NCT06033248· Memorial Sloan Kettering Cancer Center· Source
Contact: Gaetano Rocco, MD
Recruiting
A Registry for People With T-cell Lymphoma
NCT05978141· Memorial Sloan Kettering Cancer Center· Source
Contact: Steven Horwitz, MD
Recruiting
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT05691010· Early phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Kaled Alektiar, MD
Recruiting
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
NCT05640843· Memorial Sloan Kettering Cancer Center· Source
Contact: Urvi A Shah, MD, MS
Recruiting
A Study of ZEN003694 in People With Squamous Cell Lung Cancer
NCT05607108· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Paul Paik, MD
Recruiting
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
NCT05570253· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Sherry Shen, MD
Recruiting
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
NCT05562791· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Gopakumar Iyer, MD
Active, not recruiting
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
NCT05169970· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
NCT04722172· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Recruiting
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
NCT04683679· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Atif Khan, MD
Active, not recruiting
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
NCT04757363· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)
NCT04447768· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
NCT04468841· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax
NCT04419519· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs
NCT04288375· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]
NCT03504163· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy
NCT03520491· Phase 2· Memorial Sloan Kettering Cancer Center· Source